Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling
Abstract Lung adenocarcinoma (LUAD) is the leading cause of cancer death worldwide. Circular RNAs (circRNAs) have emerged as potential key players in the onset and progression of various cancers. However, the specific roles and mechanisms of circRNAs in LUAD remain largely unexplored. Here, we aimed...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02565-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849238759956021248 |
|---|---|
| author | Xia Yang Lu Liu Zhongjian Yu Yuanlin Chen Shiting Xu Meiyuan Liu Meng Wang Huili Guo Zhiwu Zhang Bingjie Shan Silin Cai Mengting Pan Jiangyu Zhang Fengpin Wang Yanfang Zheng |
| author_facet | Xia Yang Lu Liu Zhongjian Yu Yuanlin Chen Shiting Xu Meiyuan Liu Meng Wang Huili Guo Zhiwu Zhang Bingjie Shan Silin Cai Mengting Pan Jiangyu Zhang Fengpin Wang Yanfang Zheng |
| author_sort | Xia Yang |
| collection | DOAJ |
| description | Abstract Lung adenocarcinoma (LUAD) is the leading cause of cancer death worldwide. Circular RNAs (circRNAs) have emerged as potential key players in the onset and progression of various cancers. However, the specific roles and mechanisms of circRNAs in LUAD remain largely unexplored. Here, we aimed to elucidate the role of a particular novel circRNA, circLIMK1-005 (hsa_circ_0002690), in the pathogenesis of LUAD. Our study revealed that circLIMK1-005 was upregulated in LUAD and correlated with poor patient prognosis. Functionally, circLIMK1-005 significantly promoted LUAD cell proliferation and metastasis. Mechanistically, circLIMK1-005 elevated the expression of Cyclin D1 and CDK4 proteins, thereby activating CDK4 signaling. We further demonstrated that circLIMK1-005 promoted LUAD progression by binding with RPA1 protein and activating the CDK4 pathway. In vivo experiments corroborated these findings, confirming that the circLIMK1-005/RPA1/CDK4 axis contributed to LUAD progression and was associated with poor clinical outcomes. Our study revealed a novel mechanism of the circLIMK1-005/RPA1/CDK4 axis in LUAD progression, and highlighted that targeting circLIMK1-005 could represent a potential therapeutic strategy for patients with LUAD. Schematic diagram of hypothesis involved in the circLIMK1-005/RPA1/CDK4 axis in LUAD progression. Figure was created with BioGDP.com. |
| format | Article |
| id | doaj-art-43f8b54779d44295b788d10e3731027f |
| institution | Kabale University |
| issn | 2058-7716 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death Discovery |
| spelling | doaj-art-43f8b54779d44295b788d10e3731027f2025-08-20T04:01:25ZengNature Publishing GroupCell Death Discovery2058-77162025-07-0111111410.1038/s41420-025-02565-yCircular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signalingXia Yang0Lu Liu1Zhongjian Yu2Yuanlin Chen3Shiting Xu4Meiyuan Liu5Meng Wang6Huili Guo7Zhiwu Zhang8Bingjie Shan9Silin Cai10Mengting Pan11Jiangyu Zhang12Fengpin Wang13Yanfang Zheng14Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityGuangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical UniversityAbstract Lung adenocarcinoma (LUAD) is the leading cause of cancer death worldwide. Circular RNAs (circRNAs) have emerged as potential key players in the onset and progression of various cancers. However, the specific roles and mechanisms of circRNAs in LUAD remain largely unexplored. Here, we aimed to elucidate the role of a particular novel circRNA, circLIMK1-005 (hsa_circ_0002690), in the pathogenesis of LUAD. Our study revealed that circLIMK1-005 was upregulated in LUAD and correlated with poor patient prognosis. Functionally, circLIMK1-005 significantly promoted LUAD cell proliferation and metastasis. Mechanistically, circLIMK1-005 elevated the expression of Cyclin D1 and CDK4 proteins, thereby activating CDK4 signaling. We further demonstrated that circLIMK1-005 promoted LUAD progression by binding with RPA1 protein and activating the CDK4 pathway. In vivo experiments corroborated these findings, confirming that the circLIMK1-005/RPA1/CDK4 axis contributed to LUAD progression and was associated with poor clinical outcomes. Our study revealed a novel mechanism of the circLIMK1-005/RPA1/CDK4 axis in LUAD progression, and highlighted that targeting circLIMK1-005 could represent a potential therapeutic strategy for patients with LUAD. Schematic diagram of hypothesis involved in the circLIMK1-005/RPA1/CDK4 axis in LUAD progression. Figure was created with BioGDP.com.https://doi.org/10.1038/s41420-025-02565-y |
| spellingShingle | Xia Yang Lu Liu Zhongjian Yu Yuanlin Chen Shiting Xu Meiyuan Liu Meng Wang Huili Guo Zhiwu Zhang Bingjie Shan Silin Cai Mengting Pan Jiangyu Zhang Fengpin Wang Yanfang Zheng Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling Cell Death Discovery |
| title | Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling |
| title_full | Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling |
| title_fullStr | Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling |
| title_full_unstemmed | Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling |
| title_short | Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling |
| title_sort | circular rna circlimk1 005 promotes the progression of lung adenocarcinoma by interacting with rpa1 protein to activate cdk4 signaling |
| url | https://doi.org/10.1038/s41420-025-02565-y |
| work_keys_str_mv | AT xiayang circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT luliu circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT zhongjianyu circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT yuanlinchen circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT shitingxu circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT meiyuanliu circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT mengwang circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT huiliguo circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT zhiwuzhang circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT bingjieshan circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT silincai circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT mengtingpan circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT jiangyuzhang circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT fengpinwang circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling AT yanfangzheng circularrnacirclimk1005promotestheprogressionoflungadenocarcinomabyinteractingwithrpa1proteintoactivatecdk4signaling |